Life Science Investing Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Life Science Investing Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
Life Science Investing Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
life science investing Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
life science investing Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
life science investing Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
life science investing Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy 28th Annual Meeting
life science investing Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
life science investing Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress
life science investing Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer 2025 Spring Scientific Meeting
New Found Gold and Maritime Enter into Definitive Agreement to Combine; Combination Creates an Emerging Canadian Gold Producer
New Found Gold and Maritime Enter into Definitive Agreement to Combine; Combination Creates an Emerging Canadian Gold Producer
